Sutro Biopharma, Inc. (STRO)

Sutro Biopharma Revenue

Sutro Biopharma had revenue of $8.52M in the quarter ending September 30, 2024, a decrease of -49.66%. This brings the company's revenue in the last twelve months to $160.96M, up 230.90% year-over-year. In the year 2023, Sutro Biopharma had annual revenue of $153.73M with 126.84% growth.

• Revenue (ttm): $160.96M
• Revenue Growth: +230.90%
• P/S Ratio: 1.19
• Revenue / Employee: $532,964
• Employees: 302
• Market Cap: 218.93M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	153.73M	85.96M	126.84%
Dec 31, 2022	67.77M	5.89M	9.52%
Dec 31, 2021	61.88M	19.16M	44.84%
Dec 31, 2020	42.72M	-14.00K	-0.03%
Dec 31, 2019	42.74M	4.32M	11.24%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.